Curing cancer has been one of the greatest conundrums in the modern medical field. To
reduce side-effects associated with the traditional cancer therapy such as radiotherapy and …

Significant progress has been made in the field of cancer immunotherapy, where the goal is
to activate or modulate the body's immune response against cancer. However, current …

Photothermal therapy (PTT) is recognized as a promising approach for cancer theranostics
via the nonradiative conversion of light into heat energy. PTT treatment is able to reduce the …

Tumor-bearing individuals have been reported to harbor increased numbers of Foxp3+
regulatory T cells (Treg), which prevent the development of efficient antitumor immune …

Tumor cells craft microenvironment to overcome growth disadvantages and adjust to escape
the immunosurveillance during tumorigenesis and metastasis. The evolving adaption to the …

Cancer immunotherapy is the most promising trend in oncology, focusing on helping or
activating the patient's immune system to identify and fight against cancer. In the last …

The therapeutic potential of adoptive cell therapy (ACT) in cancer patients was first
acknowledged 3 decades ago, but it was an esoteric approach at the time. In recent years …

Purpose.: In contrast to many other malignancies, in uveal melanoma (UM) the presence of
an immune infiltrate is associated with a bad prognosis. An analysis of the different …

The receptor for advanced glycation end products (RAGE), firstly described in 1992, is a
single-transmembrane and multiligand member of the immunoglobulin protein family. RAGE …

Catalytic nanoparticles with natural enzyme-mimicking properties, known as nanozymes,
have emerged as excellent candidate materials for cancer immunotherapy. Owing to their …